Journals / Tüberküloz ve Toraks / 2020 / Cilt: 68 - Sayı: 4

Successful treatment of COVID-19 infection in a patient with tracheostomy

Trakeostomili bir hastada COVID-19 enfeksiyonunun başarılı tedavisi

Pages
444–448
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Laboratory findings revealed lymphopenia and elevated C-reactive protein and procalcitonin levels.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Coronavirus disease 2019 (COVID-19) has been demonstrated to be the cause of emerging atypical pneumonia.
📊
Key Findings & Data:A 61-year-old male patient with tracheostomy was admitted to the hospital with dys-pnea, fever and increased tracheal secretions.
💡
Conclusion & Impact:Laboratory findings revealed lymphopenia and elevated C-reactive protein and procalcitonin levels.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Coronavirus disease 2019 (COVID-19) has been demonstrated to be the cause of emerging atypical pneumonia. In patients with tracheostomy, coro-navirus hypothetically coexists with well-known bacterial agents. A 61-year-old male patient with tracheostomy was admitted to the hospital with dys-pnea, fever and increased tracheal secretions. Laboratory findings revealed lymphopenia and elevated C-reactive protein and procalcitonin levels. Chest computed tomography showed consolidation areas and ground-glass opaci-ties more prominent in subpleural areas. Although; two consecutive RT-PCR analyses of combined nasopharengeal/oropharengeal swabs were found to be negative for SARS-CoV-2 RNA, positivity was reported for endotracheal aspirate (ETA) sample. Significant growth of Pseudomonas aeruginosa and Stenotrophomonas maltophilia was detected in the bacterial culture of ETA sample. In conclusion, clinical samples for SARS-CoV-2 should be obtained through the lower respiratory tract, if possible and if upper airway samples are negative. To the best our knowledge, our paper is the first report of the patient with tracheostomy who was treated successfully for COVID-19.

Özet

Yeni tip Coronavirüs hastalığı (COVID-19) atipik pnömoniye neden olmaktadır. Trakeostomili hastalarda sık karşılaşılan bakteriyel enfeksiyonlarla coronavirüs birlikteliği görülebilmektedir. Olgumuz 61 yaşında trakeostomi ile takip edilen erkek hasta; nefes darlığı, ateş ve trakeal sekresyonlarda artış ile hastaneye başvurdu. Laboratuvar bulgularında lenfopeni ve C-reaktif protein ve prokalsitonin düzeylerinde artış saptandı. Toraks bilgisayarlı tomografisinde subplevral alanlarda konsolidasyonlar ve buzlu cam opasiteleri daha belirgin olarak görüldü. Kombine nazofarengeal/orofarengeal sürüntülerin SARS-CoV-2 RNA için RT-PCR analizi ardışık olarak iki kez negatif saptanmasına rağmen endotrakeal aspirat örneğinde pozitiflik görüldü. Endotrakeal aspirat örneğinin bakteri kültüründe Pseudomonas aeruginosa ve Stenotrophomonas maltophilia üremeleri saptandı. Sonuç olarak SARS-CoV-2 için üst hava yolundan alınan örnekler negatifse, mikrobiyolojik örnekler mümkünse alt solunum yolundan alınmalıdır. Olgumuz literatürdeki COVID-19 tanısı ile başarılı olarak tedavi edilen sunulmuş ilk olgudur.

🔖

Cite This Article

ALTINTAŞ, N. D., KAYA, A. G., ÇİLEDAĞ, A., KAYA, A., ÖZ, M., EROL, S., ÇİFTÇİ, F., UZUN, Ç., TALAN, L., YAKUT, Ö. V., GÜLTEN, E., KARAHAN, Z. C. (2022). Successful treatment of COVID-19 infection in a patient with tracheostomy. Tüberküloz ve Toraks, Cilt: 68 - Sayı: 4, 444–448. https://ajindex.com/articles/618370

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Feng H, Liu Y, Lv M, Zhong J. A case report of COVID-19 with false negative RT-PCR test: necessity of chest CT. Japan J Radiol 2020; 38(5): 409-10
  2. Frutos-Vivar F, Esteban A, Apezteguia C, Anzueto A, Nightingale P, Gonzalez M, et al. Outcome of mechanically ventilated patients who require a tracheostomy. Crit Care Med 2005; 33(2): 290-8
  3. Epstein SK. Late complications of tracheostomy. Respir Care 2005; 50(4): 542-9
  4. Eid RC, Domingues F, Silva Barreto JK, Marra AR, Silva CV, Paes AT, et al. Successful prevention of tracheostomy associated pneumonia in step-down units. Am J Infect Control 2011; 39(6): 500-5
  5. Hase R, Kurita T, Muranaka E, Sasazawa H, Mito H, Yano Y. A case of imported COVID-19 diagnosed by PCR-positive lower respiratory specimen but with PCR-negative throat swabs. Infect Dis (London, England) 2020; 52(6): 423-6
  6. Mawaddah A, Gendeh HS, Lum SG, Marina MB. Upper respiratory tract sampling in COVID-19. The Malays J Pathol 2020; 42(1): 23-35
  7. Pan Y, Zhang D, Yang P, Poon LL, Wang Q. Viral load of SARS-CoV-2 in clinical samples. Lancet Infect Dis 2020; 20(4): 411-2
  8. Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med 2020; 58(7): 1131-4
  9. Lippi G. Sepsis biomarkers: past, present and future. Clin Chem Lab Med 2019; 57(9): 1281-3
  10. Ye Z, Zhang Y, Wang Y, Huang Z, Song B. Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review. Eur Radiol 2020: 1-9
  11. Hani C, Trieu NH, Saab I, Dangeard S, Bennani S, Chassagnon G. COVID-19 pneumonia: A review of typical CT findings and differential diagnosis. Diagn Interv Imaging 2020; 101(5): 263-8
  12. Sole ML, Talbert S, Penoyer DA, Bennett M, Sokol S, Wilson J. Comparison of respiratory infections before and after percutaneous tracheostomy. American journal of critical care: an official publication. Am Crit Care Nurs 2014; 23(6): e80-7
  13. Pawar M, Mehta Y, Khurana P, Chaudhary A, Kulkarni V, Trehan N. Ventilator-associated pneumonia: Incidence, risk factors, outcome, and microbiology. J Cardiothorac Vasc Anesth 2003; 17(1): 22-8.